Elawyers Elawyers
Ohio| Change

Gipson v. Secretary of Health and Human Services, 17-1651V. (2019)

Court: United States Court of Federal Claims Number: infdco20190415c06 Visitors: 23
Filed: Feb. 25, 2019
Latest Update: Feb. 25, 2019
Summary: (Not to be Published) DECISION AWARDING DAMAGES 1 BRIAN H. CORCORAN , Special Master . On November 1, 2017, Patsy Gipson, Trustee of Alfred A. Gipson, filed a petition seeking compensation under the National Vaccine Injury Compensation Program. 2 Petitioner alleged that Mr. Gipson suffered from Guillain-Barr syndrome ("GBS") as a result of receiving the influenza ("flu") vaccine on November 5, 2015, and that his death on January 1, 2017, was a sequela of that injury. Petition (ECF No.
More

(Not to be Published)

DECISION AWARDING DAMAGES1

On November 1, 2017, Patsy Gipson, Trustee of Alfred A. Gipson, filed a petition seeking compensation under the National Vaccine Injury Compensation Program.2 Petitioner alleged that Mr. Gipson suffered from Guillain-Barré syndrome ("GBS") as a result of receiving the influenza ("flu") vaccine on November 5, 2015, and that his death on January 1, 2017, was a sequela of that injury. Petition (ECF No. 1) at 1. Petitioner subsequently amended her petition on September 5, 2018, to remove the requested compensation for Mr. Gipson's death (thus, limiting her compensation request to damages directly attributable to Mr. Gipson's GBS injury). Amended Petition (ECF No. 22) at 1.

Thereafter, on August 24, 2018, Respondent filed his Rule 4(c) Report indicating that medical personnel of the Division of Injury Compensation Programs ("DICP"), Department of Health and Human Services concluded that Petitioner has satisfied the criteria for a GBS/flu vaccine injury as set forth in the Vaccine Injury Table ("Table"). See Rule 4(c) Report, filed Aug. 24, 2018 (ECF No. 21) at 5-6. According to Respondent, the evidence shows that Petitioner suffered GBS following administration of the flu vaccine, and that onset occurred within the time period specified in the Table. Id. at 5. Thus, Respondent indicated that based on his review of the record Petitioner satisfied all legal prerequisites for compensation under the Act. Id. at 5-6. I subsequently issued a ruling on entitlement on October 1, 2018. See ECF No. 23.

On February 25, 2019, Respondent filed a proffer proposing an award of compensation. ECF No. 28. I have reviewed the file, and based upon that review I conclude that the Respondent's proffer (as attached hereto) is reasonable. I therefore adopt it as my decision in awarding damages on the terms set forth therein.

The proffer awards:

• A lump sum payment of $176,288.00, representing Mr. Gibson's pain and suffering ($175,000.00), plus past unreimbursable expenses ($1,288.00), in the form of a check payable to Petitioner.

Proffer at I-II. These amounts represent compensation for all elements of compensation under 42 U.S.C. § 300aa-15(a) to which Petitioner is entitled.

I approve a Vaccine Program award in the requested amount set forth above to be made to Petitioner. In the absence of a motion for review filed pursuant to RCFC Appendix B, the clerk of the Court is directed to enter judgment herewith.3

IT IS SO ORDERED.

RESPONDENT'S PROFFER ON AWARD OF COMPENSATION

On November 1, 2017, Patsy Gipson, Trustee of Alfred A. Gipson ("Alfred"), ("petitioner") filed a petition for compensation alleging that Alfred suffered Guillain-Barré syndrome ("GBS"), a Table injury, as a result of an influenza ("flu") vaccine administered to him on November 5, 2015, and that his death on January 1, 2017, was a sequela of that alleged vaccine injury.

On August 24, 2018, Respondent filed his Rule 4(c) Report conceding entitlement to compensation for Alfred's Table injury of GBS, but denying that Alfred's GBS was a substantial factor in the cause of his death.

Petitioner filed an Amended Petition on September 5, 2018, withdrawing her claim for damages for Alfred's death.

On October 1, 2018, the Special Master issued an Entitlement Ruling finding that petitioner was entitled to compensation under the Vaccine Act for Alfred's GBS.

I. Items of Compensation

Based upon the evidence of record, respondent proffers that petitioner should be awarded $176,288.00 consisting of $175,000.00 for Alfred's pain and suffering, and $1,288.00 for past unreimbursable expenses related to Alfred's GBS. This represents all elements of compensation to which petitioner would be entitled under 42 U.S.C. § 300aa-15(a). Petitioner agrees.

II. Form of the Award

The parties recommend that the compensation provided to petitioner should be made through a lump sum payment of $176,288.00 in the form of a check payable to petitioner. Petitioner agrees.

Respectfully submitted, JOSEPH H. HUNT Assistant Attorney General C. SALVATORE D'ALESSIO Acting Director Torts Branch, Civil Division CATHARINE E. REEVES Deputy Director Torts Branch, Civil Division GABRIELLE M. FIELDING Assistant Director Torts Branch, Civil Division s/Lisa A. Watts LISA A. WATTS Senior Trial Attorney Torts Branch, Civil Division U.S. Department of Justice P.O. Box 146 Benjamin Franklin Station Washington, D.C. 20044-0146 Dated: February 25, 2019 Tel.: (202) 616-4099

FootNotes


1. Although this Decision has not been specified for publication, it will nevertheless be posted on the United States Court of Federal Claims website, in accordance with the E-Government Act of 2002, 44 U.S.C. § 3501 (2012). This means the Decision will be available to anyone with access to the internet. As provided by 42 U.S.C. § 300aa-12(d)(4)(B), however, the parties may object to the published decision's inclusion of certain kinds of confidential information. Specifically, under Vaccine Rule 18(b), each party has fourteen days within which to request redaction "of any information furnished by that party: (1) that is a trade secret or commercial or financial in substance and is privileged or confidential; or (2) that includes medical files or similar files, the disclosure of which would constitute a clearly unwarranted invasion of privacy." Vaccine Rule 18(b). Otherwise, the whole Decision will be available to the public in its current form. Id.
2. The Vaccine Program comprises Part 2 of the National Childhood Vaccine Injury Act of 1986, Pub. L. No. 99-660, 100 Stat. 3758, codified as amended at 42 U.S.C. §§ 300aa-10 through 34 (2012) ("Vaccine Act" or "the Act"). Individual section references hereafter will be to § 300aa of the Act (but will omit that statutory prefix).
3. Pursuant to Vaccine Rule 11(a), the parties may expedite entry of judgment by each filing (either jointly or separately) a notice renouncing their right to seek review.
Source:  Leagle

Can't find what you're looking for?

Post a free question on our public forum.
Ask a Question
Search for lawyers by practice areas.
Find a Lawyer